share_log

Benson Hill Analyst Ratings

ベンソン・ヒルのアナリスト評価

Benzinga Analyst Ratings ·  2022/09/30 09:22
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/30/2022 102.43% UBS → $5 Initiates Coverage On → Buy
05/19/2022 102.43% Barclays $8 → $5 Maintains Overweight
03/29/2022 223.89% Barclays $10 → $8 Maintains Overweight
03/16/2022 142.91% Goldman Sachs $9 → $6 Maintains Neutral
12/09/2021 264.37% Oppenheimer → $9 Initiates Coverage On → Outperform
11/23/2021 264.37% Goldman Sachs → $9 Initiates Coverage On → Neutral
10/25/2021 304.86% Barclays → $10 Initiates Coverage On → Overweight

Benson Hill Questions & Answers

What is the target price for Benson Hill (BHIL)?

The latest price target for Benson Hill (NYSE: BHIL) was reported by UBS on September 30, 2022. The analyst firm set a price target for $5.00 expecting BHIL to rise to within 12 months (a possible 102.43% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Benson Hill (BHIL)?

The latest analyst rating for Benson Hill (NYSE: BHIL) was provided by UBS, and Benson Hill initiated their buy rating.

When is the next analyst rating going to be posted or updated for Benson Hill (BHIL)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benson Hill, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benson Hill was filed on September 30, 2022 so you should expect the next rating to be made available sometime around September 30, 2023.

Is the Analyst Rating Benson Hill (BHIL) correct?

While ratings are subjective and will change, the latest Benson Hill (BHIL) rating was a initiated with a price target of $0.00 to $5.00. The current price Benson Hill (BHIL) is trading at is $2.47, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする